Floatz logo

Folic Acid

Stomatitis

Niels FristrupSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Stomatitis cohort.

Asset / SponsorPhaseRating
Datopotamab Deruxtecan
AstraZeneca
Phase 4BB
Methylene Blue
Mayo Clinic
Phase 3BB
DEXAMETHASONE
AstraZeneca
Phase 4BB
Palifermin
Swedish Orphan Biovitrum
Phase 3B
MECLOCYCLINE SULFOSALICYLATE
Mucosal Therapeutics
Phase 2B

View all 17 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →